Cargando…
Withaferin A: a potential therapeutic agent against COVID-19 infection
The outbreak and continued spread of the novel coronavirus disease 2019 (COVID-19) is a preeminent global health threat that has resulted in the infection of over 11.5 million people worldwide. In addition, the pandemic has claimed the lives of over 530,000 people worldwide. Age and the presence of...
Autores principales: | Straughn, Alex R., Kakar, Sham S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369003/ https://www.ncbi.nlm.nih.gov/pubmed/32684166 http://dx.doi.org/10.1186/s13048-020-00684-x |
Ejemplares similares
-
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
por: Straughn, Alex R., et al.
Publicado: (2019) -
Withaferin A attenuates ovarian cancer-induced cardiac cachexia
por: Kelm, Natia Q., et al.
Publicado: (2020) -
Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass
por: Straughn, Alex R., et al.
Publicado: (2021) -
Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
por: Fong, Miranda Y., et al.
Publicado: (2012) -
Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
por: Behl, Tapan, et al.
Publicado: (2020)